A Phase I/II Study of LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
Phase of Trial: Phase I/II
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Everolimus (Primary) ; Ribociclib (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 05 Jun 2018 Trial design presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 07 Jun 2017 Status changed from not yet recruiting to recruiting.
- 21 Apr 2017 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.